The global testosterone test market recorded a market valuation of US$ 100.0 million in 2023 and is expected to expand at a CAGR rate of 6.9% to reach a valuation of US$ 208.1 million by 2034. North America is leading the market with a share of about 32.4% within the global market.
The operation of male sexual organs and their regular growth depend on the levels of the hormone testosterone. It regulates sex drive, preserves muscular mass, and aids in sperm production in adult men. Testosterone is also found in females in a very small amount in the ovaries. Also, it is produced by the adrenal glands in both males and females.
In the testosterone test, the blood testosterone levels are measured. Most of the testosterone in the blood is protein-bound. The testosterone that is unattached to a protein is called free testosterone. First, the total testosterone test, which measures both attached and free testosterone, is one of the two primary testosterone assays. The second test solely measures free testosterone, and the free testosterone test can reveal more information about some medical issues. In both men and women, low or excessive testosterone levels can cause health problems.
Key Attributes | Market Insights |
---|---|
Testosterone Test Market Value, 2023 | US$ 100.0 million |
Estimated Market Value 2024 | US$ 106.6 million |
Projected Market Value 2034 | US$ 208.1 million |
CAGR (2024 to 2034) | 6.9% |
Market Share of Top 5 Countries | 58.5% |
Key Market Players | Medical EXPO, Abbexa, Imaware, LetsGetChecked, Everlywell, Boditech, myLAB Box, Verisana, Ro, Cerascreen, MediChecks, Genway Biotech, Hone Health, Humankind Ventures Ltd., Diagnostic Automation/Cortez Diagnostics Inc., Myclinic.ie, Healthy Human Labs Ltd., MyBioSource, Bluecrest Wellness and Testochecker |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
In 2023, the market for testosterone tests represented around 22.5% of the total global fertility testing market.
The market for testosterone tests has grown at a CAGR of 5.1% from 2019 to 2023, driven by an increase in demand due to rising rates of infertility, erectile dysfunction, testicular cancer, and delayed puberty.
Historical Market Value, 2023 | US$ 100.0 million |
---|---|
HCAGR, 2019 to 2033 | 5.1% |
The testosterone tests are performed using blood, saliva, and urine. The testing kits are not only used for testosterone but are now developed by combining several other hormone tests. Thus, advancements in the kit made it possible to diagnose the disease with one kit. Also, the results obtained are much easier to read and understand. The customization of the results based on age is also provided by the companies. The samples taken are pain-free and are easy to collect.
Few of the companies provide video instructions for every step to be performed, which make it easy for the patients to use and they are also provided with live support access. Also, the patients are provided with personalized medical advice with results.
The improper balance of testosterone levels in the body can lead to testicular cancer. Also in females, high levels of testosterone are proven to be the reason for developing conditions like polycystic ovarian syndrome (PCOS). The rising number of PCOS in females has also added to the growth of the testosterone test market.
Hence, owing to the factors mentioned above, the global testosterone test market is projected to grow at a CAGR of 6.9% from 2023 to 2033.
There is a growing awareness regarding the importance of testosterone levels in various health conditions, including hypogonadism, infertility, and sexual dysfunction. This awareness has led to an increased demand for testosterone testing, driving market growth.
Male infertility is a significant concern worldwide, and testosterone testing is an essential component of the diagnostic process. With the increasing prevalence of male infertility, the demand for testosterone tests is expected to rise, presenting growth prospects for the market. Also, several other factors like testicular cancer, delayed puberty, increasing infertility, and low testosterone levels are expected to drive the demand for testosterone test kits over the forecast period.
The testosterone test market has significant growth potential in emerging and developing economies. Factors such as increasing healthcare expenditure, improving healthcare infrastructure, and rising awareness about hormonal disorders contribute to the market's expansion in these regions.
The unawareness among the population regarding the availability of these test kits and also, the lack of knowledge about using the kits is a key factor that affects the growth of the market.
Testosterone tests can be expensive, especially when advanced technologies and specialized equipment are involved. The cost factor can limit access to testing for individuals with limited financial resources, impacting market growth. The cost of kits used for testosterone tests is comparatively higher than the laboratory testing. This makes it unconventional to use in developing and underdeveloped countries.
Testosterone tests are performed with blood or saliva. The tests using saliva as the sample in the test kit are still questioned regarding the accuracy of the results. The market's growth throughout the forecast period may be impacted by all of the above-mentioned variables.
Countries | CAGR (2024 to 2034) |
---|---|
United States | 6.4% |
Germany | 3.9% |
India | 7.0% |
United Kingdom | 6.7% |
Accounting for a market share of 89.9%, the United States is leading the market in North America.
Infertility is a key concern and a common problem in males. Infertility in males is rising in the United States. Infertility issues in men are increasing this market in this region.
Testosterone imbalances, such as hypogonadism, are becoming more prevalent in the United States population. Factors such as sedentary lifestyles, obesity, stress, and aging contribute to the rising incidence of these conditions. The need for diagnosing and monitoring testosterone levels drives the demand for testosterone tests.
The Indian market for testosterone tests hold a share of 50.0% of the South Asian market.
Erectile dysfunction is a common complication observed in India. Erectile dysfunction is observed to be common among type 2 diabetes patients. Also, other factors are adding to the erectile dysfunction in males. Thus, it is expected to increase the market for testosterone tests.
The United Kingdom is expected to rise at a CAGR of 6.7% over the forecast period.
Low levels of testosterone cause testicular cancer, increasing the demand for testosterone testing in the country. Similar to other developed countries, the United Kingdom is witnessing a rise in the prevalence of testosterone-related disorders such as hypogonadism.
Lifestyle factors, the aging population, and other health conditions contribute to the increased incidence of testosterone imbalances. This drives the demand for testosterone tests for diagnosis and monitoring.
Germany held a significant share of 27.1% of the Europe testosterone test market.
The increasing healthcare expenditure and the rise in disposable income are the main reasons for boosting the market growth of testosterone tests in Germany. Other than this, the rise in awareness about the importance of testosterone for overall health and well-being is also fuelling market growth. This has led to an increased demand for testosterone tests among men of all age groups.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The blood sample for testosterone tests had a prominent market share of 45.2% in 2024. The segment is anticipated to grow at a CAGR of 7.0% during the forecast period.
Top Sample Type | Blood Sample |
---|---|
Market Share in 2024 | 45.2% |
Blood samples are commonly used samples for testing any kind of hormone. The blood samples are considered to give accurate results as compared to any other samples. The reliability of the results makes it the most used and preferred sample for testosterone testing.
Males are the ones who are undergoing testosterone tests in a large number accounting for 84.5% market share.
Top Gender | Males |
---|---|
Market Share in 2024 | 84.5% |
Testosterone plays an important role in males. The deficiency or rise in the levels of testosterone causes many problems in males which makes it necessary to have a record of the testosterone levels. As males are mostly affected by the levels of testosterone, therefore they hold a significant market share of this market.
Top End-use Sector | Home Care Settings |
---|---|
Market Share in 2024 | 40.2% |
The home care settings segment accounted for a prominent market share of 40.2%.
The increasing availability of test kits for home care settings and the ease of collecting the sample also the easy availability of the results provided by the manufacturers is boosting the market for home care settings.
To gain a presence in the market, the leading testosterone test businesses are primarily focusing on increasing their market share and kit supply. Leading producers like LetsGetChecked and Everlywell employ tactical strategies like collaboration and expansion to increase the supply of testosterone test kits.
Attribute | Details |
---|---|
Forecast Period | 2024 to 2034 |
Historical Data Available for | 2019 to 2033 |
Market Analysis | US$ Million for Value |
Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa (MEA) |
Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, South Africa and North Africa |
Key Market Segments Covered | Sample type, Gender, End User, and Region |
Key Companies Profiled |
|
Pricing | Available upon Request |
The global testosterone test market is worth US$ 100.0 million in 2024 and is set to expand by 6.9% over the next ten years.
The market is expected to reach US$ 208.1 million by the end of 2033.
The increasing number of manufacturing kits having a combination of different tests, digitalized reports, and the ease of sample collection are a few key trends in this market.
The United States, Germany, the United Kingdom, India, and China are expected to drive demand for the testosterone test industry.
North America is one of the key markets for testosterone tests, with the U.S. accounting for about 89.9% of the North American market in the year 2022.
Demand for testosterone tests in Europe is expected to register a growth of 7.2% over the next ten years.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Market Round Offs
1.5. FMI Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Trends & Dynamics
3.1. Per capita spending on digital scales
3.2. Key Trends Impacting the Market
3.3. Sample Type Innovation / Development Trends
3.3.1. Latest Trends and Demands
3.3.2. Latest Innovations and New Launches
3.4. Future Prospects of the Testosterone Tests Industry
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunity Analysis
4. Value-Added Insights
4.1. Product Adoption / Usage Analysis
4.2. Tests USPs/Features Analysis
4.3. New Tests Launches
4.4. Regulatory Landscape, by Country
4.5. PESTEL Analysis
4.6. Porter’s Five Force Analysis
4.7. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Player’s Historic Growth
5.2.2. Market Consolidation Activities
5.2.3. Increasing Prevalence of Hormonal Disorders
5.2.4. Tests Adoption / Analysis Rules
5.2.5. New Tests Development & Applications
5.2.6. Increasing Focus on Male Health
6. Global Market Demand Volume (Units) Analysis 2012 to 2022 and Forecast, 2023 to 2033
6.1. Historical Market Volume (Units) Analysis, 2012 to 2022
6.2. Current and Future Market Volume (Units) Projections, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis *Per Capita Consumption
7. Global Market - Pricing Analysis
7.1. Regional Pricing Analysis By Sample Type
7.2. Global Average Pricing Analysis Benchmark
7.3. Pricing Assumptions
8. Global Market Demand (in Value or Size in US$ Million) Analysis 2012 to 2022 and Forecast, 2023 to 2033
8.1. Historical Market Value (US$ Million) Analysis, 2012 to 2022
8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
8.3. Revenue Opportunity Scenario- Likely/Conservative/Optimistic
9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Sample Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) and Volume (Units) By Sample Type, 2012 to 2022
9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Sample Type, 2023 to 2033
9.3.1. Blood
9.3.2. Urine
9.3.3. Saliva
9.4. Market Attractiveness Analysis By Sample Type
10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Gender
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By Gender, 2012 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Gender, 2023 to 2033
10.3.1. Male
10.3.2. Female
10.4. Market Attractiveness Analysis By Gender
11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By End User, 2012 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
11.3.1. Hospitals
11.3.2. IVF Centers
11.3.3. Home Care settings
11.3.4. Others
11.4. Market Attractiveness Analysis By End User
12. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Region, 2012 to 2022
12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. South Asia
12.3.5. East Asia
12.3.6. Oceania
12.3.7. Middle East & Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2022
13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
13.3.1. By Country
13.3.1.1. USA
13.3.1.2. Canada
13.3.2. By Sample Type
13.3.3. By Gender
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Sample Type
13.4.3. By Gender
13.4.4. By End User
13.5. Market Trends
13.6. Market Drivers & Restraints – Intensity Mapping
13.7. Country-Level Analysis & Forecast
13.7.1. USA Market
13.7.1.1. Introduction
13.7.1.2. Market Analysis and Forecast by Market Taxonomy
13.7.1.2.1. By Sample Type
13.7.1.2.2. By Gender
13.7.1.2.3. By End User
13.7.2. Canada Market
13.7.2.1. Introduction
13.7.2.2. Market Analysis and Forecast by Market Taxonomy
13.7.2.2.1. By Sample Type
13.7.2.2.2. By Gender
13.7.2.2.3. By End User
14. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2022
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of LATAM
14.3.2. By Sample Type
14.3.3. By Gender
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Sample Type
14.4.3. By Gender
14.4.4. By End User
14.5. Market Trends
14.6. Market Drivers & Restraints – Intensity Mapping
14.7. Country Level Analysis & Forecast
14.7.1. Brazil Market
14.7.1.1. Introduction
14.7.1.2. Market Analysis and Forecast by Market Taxonomy
14.7.1.2.1. By Sample Type
14.7.1.2.2. By Gender
14.7.1.2.3. By End User
14.7.2. Mexico Market
14.7.2.1. Introduction
14.7.2.2. Market Analysis and Forecast by Market Taxonomy
14.7.2.2.1. By Sample Type
14.7.2.2.2. By Gender
14.7.2.2.3. By End User
14.7.3. Argentina Market
14.7.3.1. Introduction
14.7.3.2. Market Analysis and Forecast by Market Taxonomy
14.7.3.2.1. By Sample Type
14.7.3.2.2. By Gender
14.7.3.2.3. By End User
15. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. UK
15.3.1.2. Germany
15.3.1.3. France
15.3.1.4. Italy
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Sample Type
15.3.3. By Gender
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Sample Type
15.4.3. By Gender
15.4.4. By End User
15.5. Market Trends
15.6. Market Drivers & Restraints – Intensity Mapping
15.7. Country Level Analysis & Forecast
15.7.1. UK Market
15.7.1.1. Introduction
15.7.1.2. Market Analysis and Forecast by Market Taxonomy
15.7.1.2.1. By Sample Type
15.7.1.2.2. By Gender
15.7.1.2.3. By End User
15.7.2. Germany Market
15.7.2.1. Introduction
15.7.2.2. Market Analysis and Forecast by Market Taxonomy
15.7.2.2.1. By Sample Type
15.7.2.2.2. By Gender
15.7.2.2.3. By End User
15.7.3. France Market
15.7.3.1. Introduction
15.7.3.2. Market Analysis and Forecast by Market Taxonomy
15.7.3.2.1. By Sample Type
15.7.3.2.2. By Gender
15.7.3.2.3. By End User
15.7.4. Spain Market
15.7.4.1. Introduction
15.7.4.2. Market Analysis and Forecast by Market Taxonomy
15.7.4.2.1. By Sample Type
15.7.4.2.2. By Gender
15.7.4.2.3. By End User
15.7.5. Italy Market
15.7.5.1. Introduction
15.7.5.2. Market Analysis and Forecast by Market Taxonomy
15.7.5.2.1. By Sample Type
15.7.5.2.2. By Gender
15.7.5.2.3. By End User
15.7.6. BENELUX Market
15.7.6.1. Introduction
15.7.6.2. Market Analysis and Forecast by Market Taxonomy
15.7.6.2.1. By Sample Type
15.7.6.2.2. By Gender
15.7.6.2.3. By End User
15.7.7. Russia Market
15.7.7.1. Introduction
15.7.7.2. Market Analysis and Forecast by Market Taxonomy
15.7.7.2.1. By Sample Type
15.7.7.2.2. By Gender
15.7.7.2.3. By End User
16. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Gender
16.3.3. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Sample Type
16.4.3. By Gender
16.4.4. By End User
16.5. Market Trends
16.6. Market Drivers & Restraints – Intensity Mapping
16.7. Country Level Analysis & Forecast
16.7.1. China Market
16.7.1.1. Introduction
16.7.1.2. Market Analysis and Forecast by Market Taxonomy
16.7.1.2.1. By Sample Type
16.7.1.2.2. By Gender
16.7.1.2.3. By End User
16.7.2. Japan Market
16.7.2.1. Introduction
16.7.2.2. Market Analysis and Forecast by Market Taxonomy
16.7.2.2.1. By Sample Type
16.7.2.2.2. By Gender
16.7.2.2.3. By End User
16.7.3. South Korea Market
16.7.3.1. Introduction
16.7.3.2. Market Analysis and Forecast by Market Taxonomy
16.7.3.2.1. By Sample Type
16.7.3.2.2. By Gender
16.7.3.2.3. By End User
17. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Indonesia
17.3.1.3. Thailand
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Sample Type
17.3.3. By Gender
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Sample Type
17.4.3. By Gender
17.4.4. By End User
17.5. Market Trends
17.6. Market Drivers & Restraints – Intensity Mapping
17.7. Country Level Analysis & Forecast
17.7.1. India Market
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast by Market Taxonomy
17.7.1.2.1. By Sample Type
17.7.1.2.2. By Gender
17.7.1.2.3. By End User
17.7.2. Indonesia Market
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast by Market Taxonomy
17.7.2.2.1. By Sample Type
17.7.2.2.2. By Gender
17.7.2.2.3. By End User
17.7.3. Thailand Market
17.7.3.1. Introduction
17.7.3.2. Market Analysis and Forecast by Market Taxonomy
17.7.3.2.1. By Sample Type
17.7.3.2.2. By Gender
17.7.3.2.3. By End User
17.7.4. Malaysia Market
17.7.4.1. Introduction
17.7.4.2. Market Analysis and Forecast by Market Taxonomy
17.7.4.2.1. By Sample Type
17.7.4.2.2. By Gender
17.7.4.2.3. By End User
18. Oceania Market Analysis 2012 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Sample Type
18.3.3. By Gender
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Sample Type
18.4.3. By Gender
18.4.4. By End User
18.5. Market Trends
18.6. Market Drivers & Restraints – Intensity Mapping
18.7. Country Level Analysis & Forecast
18.7.1. Australia Market
18.7.1.1. Introduction
18.7.1.2. Market Analysis and Forecast by Market Taxonomy
18.7.1.2.1. By Sample Type
18.7.1.2.2. By Gender
18.7.1.2.3. By End User
18.7.2. New Zealand Market
18.7.2.1. Introduction
18.7.2.2. Market Analysis and Forecast by Market Taxonomy
18.7.2.2.1. By Sample Type
18.7.2.2.2. By Gender
18.7.2.2.3. By End User
19. Middle East & Africa Market Analysis 2012 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2012 to 2022
19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Türkiye
19.3.1.3. South Africa
19.3.1.4. North Africa
19.3.1.5. Rest of MEA
19.3.2. By Sample Type
19.3.3. By Gender
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Sample Type
19.4.3. By Gender
19.4.4. By End User
19.5. Market Trends
19.6. Market Drivers & Restraints – Intensity Mapping
19.7. Country Level Analysis & Forecast
19.7.1. GCC Countries Market
19.7.1.1. Introduction
19.7.1.2. Market Analysis and Forecast by Market Taxonomy
19.7.1.2.1. By Sample Type
19.7.1.2.2. By Gender
19.7.1.2.3. By End User
19.7.2. Türkiye Market
19.7.2.1. Introduction
19.7.2.2. Market Analysis and Forecast by Market Taxonomy
19.7.2.2.1. By Sample Type
19.7.2.2.2. By Gender
19.7.2.2.3. By End User
19.7.3. South Africa Market
19.7.3.1. Introduction
19.7.3.2. Market Analysis and Forecast by Market Taxonomy
19.7.3.2.1. By Sample Type
19.7.3.2.2. By Gender
19.7.3.2.3. By End User
19.7.4. North Africa Market
19.7.4.1. Introduction
19.7.4.2. Market Analysis and Forecast by Market Taxonomy
19.7.4.2.1. By Sample Type
19.7.4.2.2. By Gender
19.7.4.2.3. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Market Concentration
21. Competition Analysis
21.1. Competition Dashboard
21.2. Branding and Promotional Strategies, By Key Players
21.3. Key Development Analysis
21.4. Competition Deep Dive
21.4.1. Abbexa
21.4.1.1. Overview
21.4.1.2. Sample Type Portfolio
21.4.1.3. Key Financials
21.4.1.4. SWOT Analysis
21.4.1.5. Key Developments
21.4.1.6. Sales Footprint
21.4.1.7. Strategy Overview
21.4.1.7.1. Marketing Strategy
21.4.1.7.2. Sample Type Strategy
21.4.1.7.3. Channel Strategy
21.4.2. Imaware
21.4.3. LetsGetChecked
21.4.4. Everlywell
21.4.5. Boditech
21.4.6. myLAB Box
21.4.7. Verisana
21.4.8. Cerascreen
21.4.9. MediChecks
21.4.10. Genway Biotech
21.4.11. Hone Health
21.4.12. Humankind Ventures Ltd.
21.4.13. Diagnostic Automation/Cortez Diagnostics Inc.
21.4.14. Myclinic.ie
21.4.15. Healthy Human Labs Ltd.
21.4.16. MyBioSource
21.4.17. Bluecrest Wellness
21.4.18. Testochecker
22. Assumptions and Acronyms Used
23. Research Methodology
Explore Healthcare Insights
View Reports